Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
The Lancet. Oncology
|
November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
Philip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Cancers
|
November 26, 2022
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade <i>IDH</i>-Mutant Gliomas: A French POLA Network Study
Coline Montégut, Jean-Sébastien Guillamo, François Ducray, et al.
Journal of Neuro-Oncology
|
July 21, 2017
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
Marc Zanello, Alexandre Roux, Renata Ursu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies
Orit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
Journal of Neuro-Oncology
|
June 5, 2012
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
Georges Noel, Aymeri Huchet, Loic Feuvret, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925
Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
Neuro-Oncology
|
July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)
Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer
|
February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
Anne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2018
Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?
Laetitia Padovani, Frédérique Chapon, Nicolas André, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 22, 2016
Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients
Guillaume Louvel, Philippe Metellus, Georges Noel, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
The Lancet. Oncology
|
November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
Philip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Cancers
|
November 26, 2022
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade <i>IDH</i>-Mutant Gliomas: A French POLA Network Study
Coline Montégut, Jean-Sébastien Guillamo, François Ducray, et al.
Journal of Neuro-Oncology
|
July 21, 2017
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
Marc Zanello, Alexandre Roux, Renata Ursu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies
Orit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
Journal of Neuro-Oncology
|
June 5, 2012
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
Georges Noel, Aymeri Huchet, Loic Feuvret, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925
Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
Neuro-Oncology
|
July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)
Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer
|
February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
Anne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2018
Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?
Laetitia Padovani, Frédérique Chapon, Nicolas André, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 22, 2016
Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients
Guillaume Louvel, Philippe Metellus, Georges Noel, et al.
Page
of 10